Accidental Overdose of Paliperidone Palmitate

Accidental Overdose of Paliperidone Palmitate

Long-acting injectable (LAI) antipsychotics first introduced in 1960s are useful in the treatment of schizophrenic patients with poor medication adherence due to their maintaining feature of therapeutic plasma level without daily administration. Paliperidone Palmitate is one of such LAI antipsychoti...

Full description

Bibliographic Details
Main Authors:	Chiedozie Ojimba, Ayotomide Oyelakin, Taher Khandaker
Format:	Article
Language:	English
Published:	Hindawi Limited 2019-01-01
Series:	Case Reports in Psychiatry
Online Access:	http://dx.doi.org/10.1155/2019/7406298

Similar Items

An accidental household outbreak of paliperidone palmitate poisoning via pancake consumption in Lianyungang, China
by: Tinglu Zhang, et al.
Published: (2020-12-01)

Paliperidone palmitate-induced sialorrhoea
by: Cengiz Cengisiz, et al.
Published: (2016-03-01)

Paliperidone palmitate induced black hairy tongue
by: Bilge Burcak Annagur
Published: (2016-12-01)

Effects of Paliperidone Palmitate on Coagulation: An Experimental Study
by: Enver Demirel Yılmaz, et al.
Published: (2014-01-01)

Pharmacoeconomic analysis of paliperidone palmitate for treating schizophrenia in Greece
by: Einarson Thomas R, et al.
Published: (2012-07-01)

Manic Symptoms during a Switch from Paliperidone ER to Paliperidone Palmitate in a Patient with Schizophrenia
by: Kadir Demirci, et al.
Published: (2015-01-01)

Paliperidone Palmitate-Induced Delirium in an Adolescent with Schizophrenia: Case report
by: Hassan Mirza, et al.
Published: (2018-09-01)

Paliperidone palmitate injection for the acute and maintenance treatment of schizophrenia in adults
by: Kim S, et al.
Published: (2012-07-01)

Clinical relevance of paliperidone palmitate 3-monthly in treating schizophrenia
by: Mathews M, et al.
Published: (2019-05-01)

First-Degree Atrioventricular Block with Tachycardia from Paliperidone and Mirtazapine Overdose
by: Brian Cheung, et al.
Published: (2020-09-01)

Real-World Analysis of Switching Patients with Schizophrenia from Oral Risperidone or Oral Paliperidone to Once-Monthly Paliperidone Palmitate
by: Charmi Patel, et al.
Published: (2019-11-01)

Efficacy, safety, and impact on hospitalizations of paliperidone palmitate in recent-onset schizophrenia
by: Zhang F, et al.
Published: (2015-03-01)

Use of Long-Acting Injectable Antipsychotic in an Inpatient Unit of a Community Teaching Hospital
by: Olaniyi Olayinka, et al.
Published: (2019-01-01)

Case Report: Paliperidone Palmitate in the Management of Bipolar I Disorder With Non-compliance
by: Kanglai Li, et al.
Published: (2021-01-01)

Paliperidone Palmitate Every Three Months (PP3M) 2-Year Treatment Compliance, Effectiveness and Satisfaction Compared with Paliperidone Palmitate-Monthly (PP1M) in People with Severe Schizophrenia
by: Juan J. Fernández-Miranda, et al.
Published: (2021-04-01)

Dyskinesia, cardiac arrhythmia and partial seizure associated with paliperidone overdose: a case report
by: Antonio Villa, et al.
Published: (2015-12-01)

A case report of pregnancy and paliperidone palmitate 3‐monthly long‐acting injection
by: Rita deAzevedo Avelar, et al.
Published: (2020-12-01)

Effectiveness of 2-year treatment with aripiprazole long-acting injectable and comparison with paliperidone palmitate
by: Katy Mason, et al.
Published: (2021-07-01)

Infertility after long-acting paliperidone palmitate treatment: A case report (tur)
by: Kerim Uğur, et al.
Published: (2020-04-01)

Modeling the budget impact of long-acting injectable paliperidone palmitate in the treatment of schizophrenia in Japan
by: Mahlich J, et al.
Published: (2015-05-01)

Role of paliperidone palmitate 3-monthly in the management of schizophrenia: insights from clinical practice
by: Lopez A, et al.
Published: (2019-02-01)

Predictors of achieving remission in schizophrenia patients treated with paliperidone palmitate 3-month formulation
by: Nash AI, et al.
Published: (2019-03-01)

Paliperidone Palmitate Associated with Necrotizing Deep Tissue Infection and Sepsis Requiring Surgical Intervention
by: Jonathan G. Leung, et al.
Published: (2015-01-01)

Long-lasting extrapyramidal symptoms after multiple injections of paliperidone palmitate to treat schizophrenia
by: Takada R, et al.
Published: (2018-10-01)

Defining “Adequately Treated”: A Post Hoc Analysis Examining Characteristics of Patients with Schizophrenia Successfully Transitioned from Once-Monthly Paliperidone Palmitate to Once-Every-3-Months Paliperidone Palmitate
by: O'Donnell A, et al.
Published: (2021-01-01)

Tachycardia during Treatment with Risperidone and Paliperidone Palmitate in a Patient without Previous Cardiovascular Disease
by: Zachary Orlins, et al.
Published: (2021-01-01)

Treatment of Patients with Recently Exacerbated Schizophrenia with Paliperidone Palmitate: A Pilot Study of Efficacy and Tolerability
by: Gattaz WF, et al.
Published: (2020-09-01)

Efficacy and safety profile of paliperidone palmitate injections in the management of patients with schizophrenia: an evidence-based review
by: Emsley R, et al.
Published: (2018-01-01)

Long-term tolerability of once-monthly injectable paliperidone palmitate in subjects with recently diagnosed schizophrenia
by: Sliwa JK, et al.
Published: (2012-08-01)

The cost reduction in hospitalization associated with paliperidone palmitate in the People’s Republic of China, Korea, and Malaysia
by: Chiou CF, et al.
Published: (2015-08-01)

Quality of life of patients suffering from schizophrenia and treated with long-acting risperidone and paliperidone-palmitate
by: Mihajlović Filip, et al.
Published: (2018-01-01)

Expansion of guidance for the day 8 initiation dose of paliperidone palmitate to avoid a missed dose
by: Samtani MN, et al.
Published: (2013-05-01)

Clinical Study of Paliperidone Palmitate Long-Acting Injection Combined With Electroacupuncture in the Treatment of Methamphetamine Addicts
by: Yu Chen, et al.
Published: (2021-06-01)

Long-term efficacy and safety of paliperidone palmitate once-monthly in Chinese patients with recent-onset schizophrenia
by: Si T, et al.
Published: (2019-06-01)

Effectiveness of paliperidone palmitate one-month long-acting injection in obese vs. non-obese patients
by: Charles Dorflinger, et al.
Published: (2021-11-01)

Online Survey of Clinical Practice in Patients with Schizophrenia Treated with Long-Acting Injectable Aripiprazole or Paliperidone Palmitate
by: Such P, et al.
Published: (2021-06-01)

Accidental Ixazomib Overdose in a Patient With Multiple Myeloma
by: Parth J. Sampat MBBS, et al.
Published: (2021-05-01)

Accidental Overdose of Everolimus Secondary to Poor Patient Education
by: LaBrosse, A. D., et al.
Published: (2013)

Healthcare Resource Utilization and Costs Among Patients With Schizophrenia Switching From Oral Risperidone/Paliperidone to Once-Monthly Paliperidone Palmitate: A Veterans Health Administration Claims Analysis
by: Charmi Patel, MPH, RN, et al.
Published: (2020-01-01)

Human health benefit and burden of the schizophrenia health care pathway in Belgium: paliperidone palmitate long-acting injections
by: Sam Debaveye, et al.
Published: (2019-06-01)

Cannot write session to /tmp/vufind_sessions/sess_p8raf8k8kprk8h2utvib5dpve5